Physician profile
Robert C Broussard
NPI 1821007170
$15,055.09
in general payments reported to CMS, 2019-2025
36 companies · $3,163 in 2025
The $3,163 reported for 2025 was more than what 83% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,769 · 2020: $1,176 · 2021: $1,713 · 2022: $2,162 · 2023: $2,650 · 2024: $2,422 · 2025: $3,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,127 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,126.98 |
| Education | $108.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,724.89 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $2,532.13 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Genzyme Corporation | $1,087.82 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $793.01 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Csl Behring | $786.08 | 2019-2025 | Hizentra |
| Regeneron Healthcare Solutions, INC. | $779.69 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $664.60 | 2019-2025 | Prolastin-C Liquid, Xembify |
| Mylan Specialty L.P. | $542.72 | 2019-2024 | Yupelri |
| Amgen INC. | $456.78 | 2021-2025 | Tezspire |
| Baxter Healthcare | $453.94 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Actelion Pharmaceuticals US, INC. | $406.56 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Insmed, INC. | $403.10 | 2020-2025 | Arikayce, Brinsupri |
| Merck Sharp & Dohme LLC | $378.79 | 2022-2025 | Winrevair, Capvaxive, Keytruda |
| Viatris Specialty LLC | $290.60 | 2025 | Yupelri |
| Verona Pharma, INC. | $200.89 | 2025 | Ohtuvayre |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $195.74 | 2019-2024 | Tyvaso |
| Ani Pharmaceuticals, INC. | $191.36 | 2023-2025 | Purified Cortrophin Gel |
| Philips North America LLC | $182.02 | 2019-2024 | (Ak6) Vest Therapy |
| Bayer Healthcare Pharmaceuticals INC. | $181.99 | 2021-2023 | |
| Sanofi-Aventis U.S. LLC | $122.96 | 2021-2023 | |
| Abiomed | $121.97 | 2021 | |
| Novartis Pharmaceuticals Corporation | $111.31 | 2021-2024 | |
| Genentech USA, INC. | $90.06 | 2019-2023 | Xolair |
| Janssen Pharmaceuticals, INC | $54.07 | 2021-2022 | |
| Pfizer INC. | $39.78 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.75 | 2025 | Hyqvia |
| Gilead Sciences, INC. | $36.60 | 2019 | |
| Mallinckrodt Enterprises LLC | $33.15 | 2019 | |
| Vifor Pharma, INC. | $25.93 | 2025 | Zemaira |
| Intuitive Surgical, INC. | $25.34 | 2025 | |
| Circassia INC. | $23.18 | 2020 | |
| Mallinckrodt Hospital Products INC. | $17.67 | 2022 | |
| Electromed, INC. | $16.80 | 2024 | Smartvest |
| Inogen, INC. | $16.55 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Advanced Respiratory, INC | $15.57 | 2021 | |
| Tetraphase Pharmaceuticals, INC. | $14.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Broussard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.